Type 2 Diabetes Clinical Trials
101 studies are recruiting for type 2 diabetes in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 3
-
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
The goal of this research study is to evaluate the pathophysiologic mechanisms by which genetic variation impacts response to an FDA-approved medication commonly used to treat type 2 diabetes called oral semaglutide (Rybelsus) and to characterize the physiological response to a mixed meal tolerance…
- Stage
- Phase 4
- Ages
- 18 to 65
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
This 12-month pilot tests a nurse-led, app-based intervention to improve diabetes self-management for Medicaid patients. It includes MyChart messaging to give education, phone help on problem-solving with clinicians, and using a diabetes app to track data. The study aims to enhance self-management …
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Rutgers Health Family Medicine at Monument Square, New Brunswick, New Jersey
- Locations
- 2 in total
- Run by
- Rutgers, The State University of New Jersey
-
Exercise and Intranasal Insulin in Type 2 Diabetes
About 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologi…
- Stage
- Phase 2
- Ages
- 55 to 80
- Site
- Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick, New Jersey
- Locations
- 4 in total
- Run by
- Rutgers, The State University of New Jersey
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving…
- Stage
- Not phased
- Ages
- 12 to 20
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Run by
- Children's Hospital of Philadelphia
-
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
This observational study aims to collect detailed metabolic and physiologic data from adults with insulin-dependent type 2 diabetes mellitus following consumption of a mixed meal tolerance test. Participants will undergo frequent blood sampling over a 4-hour period after consuming a standardized li…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Illinois Institute of Technology, Chicago, Illinois
- Run by
- Clinical Nutrition Research Center, Illinois Institute of Technology
-
THC Effects on Glucose in Type 2 Diabetes
This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of …
- Stage
- Phase 1
- Ages
- 21 to 70
- Site
- UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California
- Run by
- University of California, San Diego
-
Mechanism of SGLT2 Inhibition in the Kidney
The goal of this open-label, non-randomized clinical trial is to determine what effects, if any, an FDA-approved drug class known as SGLT2 inhibitors (Canagliflozin or INVOKANA) has any protective effects on kidney function in Type 2 diabetes. We are looking for participants 18-80 years of age, who…
- Stage
- Phase 4
- Ages
- 18 to 80
- Site
- University of Michigan, Ann Arbor, Michigan
- Run by
- University of Michigan
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
A randomized clinical study to assess the efficacy of a high-protein diabetes specific formula (HPDSF) on lean muscle mass in overweight and obese patients with type 2 diabetes who are initiating treatment with incretin-mimetic drugs.
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- Joslin Diabetes Center, Boston, Massachusetts
- Run by
- Joslin Diabetes Center
-
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
The study is to assess the safety, pharmacokinetics, and pharmacodynamic profile of HMS1005 in patient with diabetes
- Stage
- Phase 1
- Ages
- 18 to 65
- Site
- Clinical Pharmacology of Miami, Miami, Florida
- Run by
- Hua Medicine Limited
-
Exercise and Protein Efficiency in T2D
In this randomized controlled trial, 30 older adults (aged> 65 years; 15 with T2D, 15 controls) will participate in a 12-week progressive exercise training program. They will undergo pre- and post-testing that includes body composition measures; oral glucose tolerance testing; cardiovascular fitnes…
- Stage
- Not phased
- Ages
- 65 and older
- Site
- Freer Hall - University of Illinois, Urbana, Illinois
- Run by
- University of Illinois at Urbana-Champaign
-
Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
The goal of this clinical trial is to pilot test different strategies to address health related social needs (HRSN) experienced by adolescent and young adult patients with type 2 diabetes and their families. The main questions it aims to answer are: * How feasible are the strategies? * How acceptab…
- Stage
- Not phased
- Ages
- 13 and older
- Site
- UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
-
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to ce…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Alliance Clinical Canoga Park (Hope Clinical Research), Canoga Park, California
- Locations
- 25 in total
- Run by
- Housey Healthcare ULC
-
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether adipocyte-directed t…
- Stage
- Phase 4
- Ages
- 30 to 70
- Site
- Stanford University, Palo Alto, California
- Locations
- 2 in total
- Run by
- Stanford University
-
Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
A Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + Glycemic Excursion Minimization (RC+GEM); a program that provides RC in addition to continuous glucose monitors (CGM) within a structured, self-directed, and pe…
- Stage
- Not phased
- Ages
- 30 to 80
- Site
- University of Colorado Department of Family Medicine, Aurora, Colorado
- Locations
- 2 in total
- Run by
- Chiara Fabris, PhD
-
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function
This study is being done to evaluate how a ketone ester (KE) supplement affects heart function and health in people with diabetes compared to a placebo supplement (made with standard food ingredients that do not contain ketone esters).
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- The Ross Heart Hospital, Columbus, Ohio
- Run by
- Ohio State University
-
The Food for Health Study
The project, called Food for Health (F4H), will study a new Produce Prescription Program (PPP) designed for rural Native American older adults. The study is based in the Confederated Salish and Kootenai Tribes (CSKT) of the Flathead Indian Reservation in Montana. In this community, many older adult…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Arlee Health Center, Arlee, Montana
- Run by
- University of Montana
-
Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal…
- Stage
- Not phased
- Ages
- 30 to 55
- Site
- University of Colorado, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
IH, Brain Health, and T2D
The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).
- Stage
- Not phased
- Ages
- 60 to 85
- Site
- University of Iowa, Iowa City, Iowa
- Run by
- Darren P Casey
-
Diabetes Body Project 2
The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 diabetes (T2D) called the Diabetes Body Project 2 (DBP2). The Diabetes Body Project 2 (DBP2) will be adapted from the Diabetes Body Project, wh…
- Stage
- Not phased
- Ages
- 18 to 40
- Site
- Joslin Diabetes Center, Boston, Massachusetts
- Run by
- Joslin Diabetes Center
-
Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
The goal of this IDEAL project is to examine the effectiveness and implementation process of the video-based Diabetes Self-Management Education and Support (DSMES) + community health worker (CHW) (hereafter: "IDEAL") intervention compared with a wait-list control group (hereafter: "CONTROL") to imp…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- NYU Langone Health, New York, New York
- Run by
- NYU Langone Health
-
PILI 'Āina Household
Native Hawaiians' traditional lifestyles and diets ensured the mutual health and well-being of the land and its inhabitants, which stand in stark contrast to the disproportionately high prevalence of diet-related, cardiometabolic diseases they experience today. In this project, the investigators wi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Kula no nā Po'e Hawai'i, Honolulu, Hawaii
- Locations
- 2 in total
- Run by
- University of Hawaii
-
'Ai Pono Cooking Demonstrations
Native Hawaiians' traditional lifestyles and diets ensured the mutual health and well-being of the land and its inhabitants, which stand in stark contrast to the disproportionately high prevalence of diet-related, cardiometabolic diseases they experience today. In this project, the investigators wi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Kula no na Poe Hawaii, Honolulu, Hawaii
- Locations
- 2 in total
- Run by
- University of Hawaii
-
Food and Fitness With Medicine (FFWM)
Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examin…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Martha Morehouse, Columbus, Ohio
- Locations
- 4 in total
- Run by
- Ohio State University
-
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
- Stage
- Not phased
- Ages
- 18 to 60
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.